BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Isconova AB 

Kungsgatan 109

Uppsala    SE-751 83  Sweden
Phone: 46-18-161700 Fax: 46-18-161701


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





 Company News
Isconova Interim Report January – June 2013 8/27/2013 9:02:08 AM    More...
Isconova Applies for Delisting 8/22/2013 9:47:18 AM    More...
Novavax, Inc. (NVAX) Acquires Isconova; Extends Public Tender Offer Period for Remaining Isconova Shareholders 7/31/2013 9:40:40 AM    More...
Novavax, Inc. (NVAX) and Isconova to Combine; Novavax' Swedish Prospectus Approved 7/8/2013 9:47:29 AM    More...
Novavax, Inc. (NVAX) Offers to Buy All Outstanding Shares of Isconova for $29.6 Million 6/4/2013 9:31:57 AM    More...
Isconova to Present at "Influenza Vaccines for the World Conference" 10/11/2012 10:59:19 AM    More...
Isconova's Adjuvant Matrix-M™ in Clinical Trial With Malaria Vaccine 10/8/2012 10:54:37 AM    More...
Isconova Carries Out a Fully Guaranteed Rights Issue of Approximately SEK 50 Million 8/27/2012 11:44:31 AM    More...
Isconova's Adjuvant Matrix-M Approved by FDA for an IND Clinical Trial 8/15/2012 10:22:59 AM    More...
Isconova Concludes Partnership With Virbac S.A. (FR:PVIRP) 7/25/2012 9:40:58 AM    More...
123

//-->